Skip to main content
Perfusate for optimized gene delivery to donor organs undergoing ex vivo machine perfusion

Perfusate for optimized gene delivery to donor organs undergoing ex vivo machine perfusion

Unmet Need Effective gene delivery is notoriously difficult to achieve to an entire target organ. Gene therapies have traditionally been administered intravascularly, requiring high vector doses to attain therapeutic levels of expression. Because of this…

Read More

Isolated organ viral, theraputic or cell therapy delivery

Isolated organ viral, theraputic or cell therapy delivery

Value proposition Cardiovascular diseases (CVD) remain the leading cause of death worldwide. The number of CVD patients with heart failure (HF) in the US is approaching 6.5 million adults and is estimated to increase by…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us